C.M. Bidwell & Associates’s Alkermes ALKS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$70K Sell
1,981
-649
-25% -$20.1K 0.03% 196
2025
Q4
$73.6K Buy
+2,630
New +$78.8K 0.03% 210
2024
Q2
Sell
-1,375
Closed -$37.2K 480
2024
Q1
$37.2K Buy
1,375
+50
+4% +$1.42K 0.03% 242
2023
Q4
$36.8K Hold
1,325
0.03% 239
2023
Q3
$37.1K Buy
+1,325
New +$38.8K 0.03% 303

Other funds holding ALKS

C.M. Bidwell & Associates's ALKS Position: Q1 2026 in Review

C.M. Bidwell & Associates reduced its Alkermes (ALKS) stake by 25% in Q1 2026, selling an estimated $20.1K and leaving 1,981 shares worth $70K. The position accounts for 0.03% of the portfolio, ranked #196.

C.M. Bidwell & Associates first reported a position in ALKS in Q3 2023 and has held it in 5 quarters since. The position peaked at $73.6K in Q4 2025. 389 funds tracked by Wall St. Rank hold ALKS as of Q1 2026.

  • C.M. Bidwell & Associates held 1,981 shares of Alkermes worth $70K as of Q1 2026.
  • C.M. Bidwell & Associates sold 649 Alkermes shares in Q1 2026, an estimated $20.1K.
  • Alkermes made up 0.03% of C.M. Bidwell & Associates's portfolio in Q1 2026, its #196 holding.
  • C.M. Bidwell & Associates first reported a position in Alkermes in Q3 2023 and has held it in 5 quarters since.
  • C.M. Bidwell & Associates's Alkermes position peaked at $73.6K in Q4 2025.
  • 389 funds tracked by Wall St. Rank held Alkermes as of Q1 2026.

Based on C.M. Bidwell & Associates's 13F filing for Q1 2026, filed 15 May 2026.